Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancements and Prospects in Cathode Materials for Aqueous Zinc-Ion Batteries: Mechanisms, Challenges and Modification Strategies.

Molecules (Basel, Switzerland)·2025
Same author

Comparison of growth features and cancer stem cell prevalence in intrahepatic and extrahepatic cholangiocarcinoma cell lines.

Clinical and experimental hepatology·2022
Same author

The Ciji-Hua'ai-Baosheng II Formula Attenuates Chemotherapy-Induced Anorexia in Mice With H<sub>22</sub> Hepatocellular Carcinoma.

Frontiers in pharmacology·2021
Same author

Long-term application of hydroxychloroquine could not prevent the infection of COVID-19.

Journal of infection in developing countries·2020
Same author

Role of Traditional Chinese Medicine in the Management of Viral Pneumonia.

Frontiers in pharmacology·2020
Same author

Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines.

Annals of hepatology·2020

Related Experiment Video

Updated: Jul 3, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Examining the evidence: complementary adjunctive therapies for multiple sclerosis.

Mike Namaka1, Arla Crook, Andrea Doupe

  • 1Faculty of Pharmacy, University of Manitoba, Department of Neurology, Health Sciences Centre, Winnipeg, Manitoba, Canada. namakamp@ms.umanitoba.ca

Neurological Research
|July 18, 2008
PubMed
Summary

Vitamin D shows promise for multiple sclerosis (MS) treatment, but evidence for other non-conventional therapies like bee venom therapy (BVT) is limited. More research is needed to guide patient and physician choices.

More Related Videos

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation (tDCS) in Multiple Sclerosis (MS)
08:18

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation (tDCS) in Multiple Sclerosis (MS)

Published on: December 26, 2015

Related Experiment Videos

Last Updated: Jul 3, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation (tDCS) in Multiple Sclerosis (MS)
08:18

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation (tDCS) in Multiple Sclerosis (MS)

Published on: December 26, 2015

Area of Science:

  • Neurology
  • Complementary and Alternative Medicine

Background:

  • Multiple sclerosis (MS) management often involves exploring non-conventional therapies alongside standard treatments.
  • Patient interest in alternative approaches like bee venom therapy (BVT), vitamins, and herbal products for MS is significant.

Purpose of the Study:

  • To comprehensively review and evaluate the efficacy and safety of frequently used non-conventional therapies for multiple sclerosis (MS).
  • To assess the evidence base for various alternative treatments, including bee venom therapy, vitamin D, and other supplements.

Main Methods:

  • Literature search of major databases (MEDLINE, PubMed, Cochrane, Toxnet) from 1990-2006.
  • Classification of evidence based on American Academy of Neurology (AAN) guidelines.
  • Analysis of available studies, noting the prevalence of anecdotal reports and suboptimal clinical data.

Main Results:

  • Bee venom therapy (BVT) has minimal supporting evidence for MS, with risks of anaphylaxis and unidentified active components.
  • Vitamin D supplementation shows the most promising evidence for prophylactic use in MS.
  • Limited evidence exists for other supplements like alpha-lipoic acid (ALA), luteolin, evening primrose oil, and vitamin B12, not supporting their prophylactic use.

Conclusions:

  • Prophylactic vitamin D is a viable adjunctive therapy for MS based on current evidence.
  • Lack of conclusive evidence for many non-conventional treatments necessitates caution, despite patient interest and accessibility.
  • Controlled, evidence-based trials are crucial for healthcare professionals to confidently recommend or advise against these alternative therapies.